Health

A Washington state resident succumbed to H5N5 bird flu on November 21, 2025—the world's first human death from this avian-only...

Cranial ultrasound—bedside beacon for pediatric neurology—shines brighter in 2025, with fresh evidence affirming its safety and supremacy for monitoring infant...

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025—a 14.8% CAGR to $25.43B by 2035—per FMI's June forecast, with ctDNA...

FluMist Home's self-administered nasal spray vaccine surges to 85% efficacy against severe influenza in 2025-2026 trials, outpacing traditional shots' 40-60%...

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025—a 14.8% CAGR to $25.43B by 2035—per FMI's June forecast, with ctDNA...

Nanoparticle vaccines erupt as oncology's alchemical vanguard in 2025, with UMass Amherst's super-adjuvant platform—lipid-encased STING/TLR4 agonists—halting melanoma in 69% of...

Health horizons brighten with nasal flu vaccine's 85% efficacy surge in 2025-2026 trials, FluMist Home's self-spray outpacing shots' 40-60% by...

Nanoparticle vaccines erupt as oncology's alchemical vanguard in 2025, with UMass Amherst's super-adjuvant platform—lipid-encased STING/TLR4 agonists—halting melanoma in 69% of...

FluMist Home bursts onto the scene in August 2025 as the first self-administered nasal spray flu vaccine, greenlit by FDA...

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025, a 14.8% CAGR rocket to $25.43B by 2035, per FMI's June...